Trials / Conditions / Endometrial Carcinosarcoma
Endometrial Carcinosarcoma
5 registered clinical trials studyying Endometrial Carcinosarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma NCT05156268 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Terminated | A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) NCT05001282 | Elucida Oncology | Phase 1 / Phase 2 |
| Recruiting | Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib NCT03651206 | ARCAGY/ GINECO GROUP | Phase 2 / Phase 3 |
| Active Not Recruiting | Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded t NCT04106414 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer NCT03015129 | Memorial Sloan Kettering Cancer Center | Phase 2 |